Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial

R. Dodel, A. Rominger, P. Bartenstein, F. Barkhof, K. Blennow, S. Forster, Y. Winter, J.P. Bach, J. Popp, J. Alferink, J. Wiltfang, K Buerger, M. Otto, P. Antuono, M. Jacoby, R. Richter, J. Stevens, I. Melamed, J. Goldstein, S. HaagS. Wietek, M. Farlow, F. Jessen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)233-243
JournalLancet Neurology
Volume12
Issue number3
DOIs
Publication statusPublished - 2013

Cite this